• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙酰肝素酶促进肝癌细胞的跨内皮迁移。

Heparanase Contributes To Trans-Endothelial Migration of Hepatocellular Carcinoma Cells.

作者信息

Chen Xiaopeng, Jiang Wen, Yue Chaofu, Zhang Wenjun, Tong Chaogang, Dai Dafei, Cheng Bin, Huang Chen, Lu Linming

机构信息

Department of Hepatobiliary Surgery, Yijishan Hospital of Wannan Medical College, Wuhu 241001, China.

Department of General Surgery, Maanshan People's Hospital, Maanshan 243000, China.

出版信息

J Cancer. 2017 Sep 16;8(16):3309-3317. doi: 10.7150/jca.20159. eCollection 2017.

DOI:10.7150/jca.20159
PMID:29158804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5665048/
Abstract

The overall outcome of patients with hepatocellular carcinoma (HCC) is still very poor due to its high metastasis and recurrence rate. During metastasis, trans-endothelial migration (TEM) of HCC cells is a key step. Heparanase (HPSE) is an endo-beta-glucuronidase and exerts prometastatic properties for normal and tumor-derived cells. However, it is remains unclear that HPSE contributes to TEM of HCC cells. In this study, human umbilical vein endothelial cells-C (HUVEC-C) was used to simulate vascular endothelial cells (VECs), and the HCCLM3 cells with high HPSE expression were chosen and used for TEM assay and experiment. As results, we found that HCCLM3 cells showed higher TEM rate compared with other HCC cells. Downregulation or inhibition of HPSE activity resulted in suppression of TEM of HCC cells both and . Our findings suggest that HPSE contributes to TEM of HCC cells, which may be a new biological function of HPSE.

摘要

由于肝细胞癌(HCC)的高转移和复发率,其患者的总体预后仍然很差。在转移过程中,肝癌细胞的跨内皮迁移(TEM)是关键步骤。乙酰肝素酶(HPSE)是一种内切β-葡萄糖醛酸酶,对正常细胞和肿瘤来源细胞具有促转移特性。然而,HPSE是否有助于肝癌细胞的TEM尚不清楚。在本研究中,使用人脐静脉内皮细胞-C(HUVEC-C)模拟血管内皮细胞(VEC),并选择HPSE高表达的HCCLM3细胞用于TEM测定和实验。结果,我们发现HCCLM3细胞与其他肝癌细胞相比显示出更高的TEM率。HPSE活性的下调或抑制导致肝癌细胞的TEM均受到抑制。我们的研究结果表明,HPSE有助于肝癌细胞的TEM,这可能是HPSE的一种新生物学功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236c/5665048/824733a8bfb2/jcav08p3309g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236c/5665048/fc1a1545d2a4/jcav08p3309g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236c/5665048/e6db88685daa/jcav08p3309g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236c/5665048/3dcb6be57600/jcav08p3309g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236c/5665048/7fb46195fb0d/jcav08p3309g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236c/5665048/cb8c7331619c/jcav08p3309g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236c/5665048/1756444ad76e/jcav08p3309g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236c/5665048/824733a8bfb2/jcav08p3309g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236c/5665048/fc1a1545d2a4/jcav08p3309g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236c/5665048/e6db88685daa/jcav08p3309g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236c/5665048/3dcb6be57600/jcav08p3309g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236c/5665048/7fb46195fb0d/jcav08p3309g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236c/5665048/cb8c7331619c/jcav08p3309g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236c/5665048/1756444ad76e/jcav08p3309g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236c/5665048/824733a8bfb2/jcav08p3309g007.jpg

相似文献

1
Heparanase Contributes To Trans-Endothelial Migration of Hepatocellular Carcinoma Cells.乙酰肝素酶促进肝癌细胞的跨内皮迁移。
J Cancer. 2017 Sep 16;8(16):3309-3317. doi: 10.7150/jca.20159. eCollection 2017.
2
[Heparanase promotes trans-endothelial migration of hepatocarcinoma cells by inducing apoptosis of microvascular endothelial cells].[乙酰肝素酶通过诱导微血管内皮细胞凋亡促进肝癌细胞的跨内皮迁移]
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Aug 30;40(8):1065-1071. doi: 10.12122/j.issn.1673-4254.2020.08.01.
3
Heparanase induces necroptosis of microvascular endothelial cells to promote the metastasis of hepatocellular carcinoma.乙酰肝素酶诱导微血管内皮细胞坏死性凋亡以促进肝细胞癌转移。
Cell Death Discov. 2021 Feb 17;7(1):33. doi: 10.1038/s41420-021-00411-5.
4
Downregulation of Heparanase Expression Results in Suppression of Invasion, Migration, and Adhesion Abilities of Hepatocellular Carcinoma Cells.乙酰肝素酶表达下调导致肝癌细胞侵袭、迁移及黏附能力受到抑制。
Biomed Res Int. 2015;2015:241983. doi: 10.1155/2015/241983. Epub 2015 Dec 29.
5
PI-88 inhibits postoperative recurrence of hepatocellular carcinoma via disrupting the surge of heparanase after liver resection.PI-88通过抑制肝切除术后乙酰肝素酶的激增来抑制肝细胞癌的术后复发。
Tumour Biol. 2016 Mar;37(3):2987-98. doi: 10.1007/s13277-015-4085-8. Epub 2015 Sep 28.
6
Synthesized multiple antigenic polypeptide vaccine based on B-cell epitopes of human heparanase could elicit a potent antimetastatic effect on human hepatocellular carcinoma in vivo.基于人乙酰肝素酶 B 细胞表位的合成多抗原肽疫苗可在体内诱导有效的抗人肝癌转移作用。
PLoS One. 2013;8(1):e52940. doi: 10.1371/journal.pone.0052940. Epub 2013 Jan 7.
7
Heparanase (HPSE) gene polymorphism (rs12503843) contributes as a risk factor for hepatocellular carcinoma (HCC): a pilot study among Egyptian patients.乙酰肝素酶(HPSE)基因多态性(rs12503843)是肝细胞癌(HCC)的一个危险因素:埃及患者的一项初步研究。
J Genet Eng Biotechnol. 2021 Jan 7;19(1):3. doi: 10.1186/s43141-020-00106-x.
8
Heparanase is involved in the proliferation and invasion of nasopharyngeal carcinoma cells.乙酰肝素酶参与鼻咽癌细胞的增殖和侵袭。
Oncol Rep. 2013 May;29(5):1888-94. doi: 10.3892/or.2013.2325. Epub 2013 Mar 5.
9
Evaluation of the Antitumor Efficacy of RNAi-Mediated Inhibition of CDC20 and Heparanase in an Orthotopic Liver Tumor Model.在原位肝肿瘤模型中评估RNA干扰介导的细胞分裂周期蛋白20(CDC20)和乙酰肝素酶抑制的抗肿瘤疗效
Cancer Biother Radiopharm. 2015 Aug;30(6):233-9. doi: 10.1089/cbr.2014.1799. Epub 2015 Jul 1.
10
Multiple antigenic polypeptide composed of heparanase B‑cell epitopes shrinks human hepatocellular carcinoma in mice.由乙酰肝素酶B细胞表位组成的多抗原多肽可使小鼠体内的人肝细胞癌缩小。
Oncol Rep. 2015 Mar;33(3):1248-56. doi: 10.3892/or.2014.3679. Epub 2014 Dec 18.

引用本文的文献

1
alters heparanase expression and reduces tumor metastasis.改变肝素酶的表达并降低肿瘤转移。
Int J Med Sci. 2021 Jun 11;18(13):2981-2989. doi: 10.7150/ijms.60281. eCollection 2021.
2
MicroRNA-219a-2-3p modulates the proliferation of thyroid cancer cells via the HPSE/cyclin D1 pathway.微小RNA-219a-2-3p通过HPSE/细胞周期蛋白D1途径调节甲状腺癌细胞的增殖。
Exp Ther Med. 2021 Jun;21(6):659. doi: 10.3892/etm.2021.10091. Epub 2021 Apr 20.
3
Heparanase induces necroptosis of microvascular endothelial cells to promote the metastasis of hepatocellular carcinoma.

本文引用的文献

1
Downregulation of Heparanase Expression Results in Suppression of Invasion, Migration, and Adhesion Abilities of Hepatocellular Carcinoma Cells.乙酰肝素酶表达下调导致肝癌细胞侵袭、迁移及黏附能力受到抑制。
Biomed Res Int. 2015;2015:241983. doi: 10.1155/2015/241983. Epub 2015 Dec 29.
2
Establishment of a dual-color fluorescence tracing orthotopic transplantation model of hepatocellular carcinoma.建立肝癌双色荧光示踪原位移植模型。
Mol Med Rep. 2016 Jan;13(1):762-8. doi: 10.3892/mmr.2015.4624. Epub 2015 Nov 30.
3
Recent data concerning heparanase: focus on fibrosis, inflammation and cancer.
乙酰肝素酶诱导微血管内皮细胞坏死性凋亡以促进肝细胞癌转移。
Cell Death Discov. 2021 Feb 17;7(1):33. doi: 10.1038/s41420-021-00411-5.
4
[Heparanase promotes trans-endothelial migration of hepatocarcinoma cells by inducing apoptosis of microvascular endothelial cells].[乙酰肝素酶通过诱导微血管内皮细胞凋亡促进肝癌细胞的跨内皮迁移]
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Aug 30;40(8):1065-1071. doi: 10.12122/j.issn.1673-4254.2020.08.01.
5
Heparanase potentiates the invasion and migration of pancreatic cancer cells via epithelial‑to‑mesenchymal transition through the Wnt/β‑catenin pathway.乙酰肝素酶通过 Wnt/β-连环蛋白通路通过上皮-间充质转化增强胰腺癌细胞的侵袭和迁移。
Oncol Rep. 2020 Aug;44(2):711-721. doi: 10.3892/or.2020.7641. Epub 2020 Jun 10.
6
Overexpression of MEF2D contributes to oncogenic malignancy and chemotherapeutic resistance in ovarian carcinoma.MEF2D的过表达促进卵巢癌的致癌恶性肿瘤形成和化疗耐药性。
Am J Cancer Res. 2019 May 1;9(5):887-905. eCollection 2019.
7
Effects of knockout of lincRNA-p21 on the proliferation, migration and invasion ability of HepG2 liver cancer cells.长链非编码RNA-p21基因敲除对肝癌HepG2细胞增殖、迁移及侵袭能力的影响
Oncol Lett. 2019 Jun;17(6):5103-5107. doi: 10.3892/ol.2019.10201. Epub 2019 Apr 1.
8
Correlation between CT features and liver function and p53 expression in hepatitis, cirrhosis and hepatocellular carcinoma.肝炎、肝硬化及肝细胞癌中CT特征与肝功能及p53表达的相关性
Oncol Lett. 2018 Oct;16(4):4297-4302. doi: 10.3892/ol.2018.9144. Epub 2018 Jul 12.
9
Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression.硫酸乙酰肝素及硫酸乙酰肝素蛋白聚糖在癌症起始与进展中的作用
Front Endocrinol (Lausanne). 2018 Aug 24;9:483. doi: 10.3389/fendo.2018.00483. eCollection 2018.
关于乙酰肝素酶的最新数据:聚焦纤维化、炎症和癌症。
Biomol Concepts. 2015 Dec;6(5-6):415-21. doi: 10.1515/bmc-2015-0021.
4
Gene silencing of heparanase results in suppression of invasion and migration of hepatoma cells.乙酰肝素酶的基因沉默导致肝癌细胞侵袭和迁移受到抑制。
World J Surg Oncol. 2014 Apr 4;12:85. doi: 10.1186/1477-7819-12-85.
5
Expressions of heparanase and upstream stimulatory factor in hepatocellular carcinoma.肝素酶和上游刺激因子在肝细胞癌中的表达。
Eur J Med Res. 2014 Aug 23;19(1):45. doi: 10.1186/s40001-014-0045-9.
6
An inducible hepatocellular carcinoma model for preclinical evaluation of antiangiogenic therapy in adult mice.一种诱导性肝细胞癌模型,用于在成年小鼠中进行抗血管生成治疗的临床前评估。
Cancer Res. 2014 Aug 1;74(15):4157-69. doi: 10.1158/0008-5472.CAN-13-2311. Epub 2014 Jun 6.
7
The potential of heparanase as a therapeutic target in cancer.肝素酶作为癌症治疗靶点的潜力。
Biochem Pharmacol. 2014 May 1;89(1):12-9. doi: 10.1016/j.bcp.2014.02.010. Epub 2014 Feb 22.
8
Characterization of heparanase-induced phosphatidylinositol 3-kinase-AKT activation and its integrin dependence.肝素酶诱导的磷酸肌醇 3-激酶-AKT 激活及其整合素依赖性的表征。
J Biol Chem. 2013 Apr 26;288(17):12366-75. doi: 10.1074/jbc.M112.435172. Epub 2013 Mar 15.
9
Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?复发性肝细胞癌的治疗策略:挽救性移植、再次切除还是射频消融?
Liver Transpl. 2013 Apr;19(4):411-9. doi: 10.1002/lt.23605. Epub 2013 Mar 17.
10
Cancer statistics, 2013.癌症统计数据,2013 年。
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.